What’s holding back digitalization of biopharma R&D?
Accenture's Tom Lehmann discusses tackling barriers to digital transformation in a thoughtful way to help companies achieve strategic imperatives.
Life Sciences research is moving fast—with advances in biological sciences generating tremendous volumes and diversity of research data. At the same time the industry needs to drive faster, more efficient and more innovative scientific research.
Through our Accenture Scientific Informatics Services business, we help our clients address business problems that redefine the way researchers and labs operate. Our team helps companies leverage digital technology to revolutionize their scientific laboratory processes to better capture, manage, integrate and analyze laboratory and scientific data.
Accenture's Scientific Research Solution helps companies leverage digital technology to revolutionize their scientific laboratory processes. See more.
View TranscriptTaking on the need to transform lab and scientific data management.
We help our clients innovate, transform, work smarter and improve research processes that can ultimately speed new therapies to patients.
We apply digital technologies to revolutionize scientific and laboratory processes. Learn more.
We focus on drug discovery innovation by combining domain expertise with a platform approach to help researchers analyze data and bring new therapies to patients. Learn more.
Leveraging design thinking, we help clients build collaborative digital labs enabling adoption of AI, machine learning and in-silico experimentation.
DRIVING DIGITAL IN BIOPHARMA
Podcast series
How Accenture helped a pharma giant unlocked greater value and performance by standardizing and harmonizing processes globally.
Accenture surveyed 128 life sciences industry leaders to better understand digital transformation in the lab.
Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and deliver better patient outcomes.
Life Sciences consultants weigh in on how pharma, biotech, medtech and consumer health companies can improve patient outcomes.
Accenture's Tom Lehmann discusses tackling barriers to digital transformation in a thoughtful way to help companies achieve strategic imperatives.